Boston Medical Center (BMC) Grayken Center for Addiction Training and Technical Assistance (TTA)

A Resource for Healthcare and Social Services Professionals

SUD Care Continuum ECHO: Suicide in Early Substance Use Disorder Recovery

February 1, 2023
12:00 pm–1:15 pm ET

As part of the twice-monthly SUD Care Continuum ECHO series, Fabiola Arbelo Cruz, MD, will present the didactic entitled, "Suicide in Early Substance Use Disorder Recovery." The didactic will be followed by an opportunity to debrief loss of a patient(s), by Franklin Cook, MA, CPC and Gabriel Quaglia, CHW, Support After a Death by Overdose (SADOD).

SUD Care Continuum ECHO: Suicide in Early Substance Use Disorder Recovery

Event sold-out

Join the waiting list

Virtual meeting

Via Zoom ID: 9914 464 0811 Passcode: SUD
Visit the meeting URL


The Grayken Center for Addiction Training and Technical Assistance, Boston Medical Center's (BMC) drop-in series Substance Use Disorder Care Continuum ECHO® (SUD Care Continuum ECHO®) offers training and support in addiction treatment, with a focus on supporting front line addiction treatment workforce. This includes health providers in Acute Treatment Services (ATS), Crisis Stabilization Services (CSS), Transitional Support Services (TSS), Opioid Treatment Programs (OTP), long-term residential program, sober and recovery homes, primary care, and psychiatry. This free, case-based tele-mentoring program is designed to increase the capacity of health care providers to implement high-quality and evidence-based addiction treatment.

Intended audience

Advanced Practice Registered Nurses (APRN), Physicians (MD/DO),Physician Assistants (PA), Nurses (LPN/RN), Social Workers (LCSW/LICSW), Licensed Mental Health Counselors (LMHC), Licensed Alcohol and Drug Counselors (LADC), Certified Alcohol/Drug Counselors (CADC), Community Health Workers (CHW), Recovery Coaches


Fabiola Arbelo Cruz, MD

Dr. Fabiola Arbelo-Cruz (she/her/hers) is an Attending Addiction Psychiatrist at the Connecticut Mental Health Center (CMHC) in New Haven, CT, and Assistant Professor of Psychiatry at Yale School of Medicine. One of her roles at CMHC includes working with the Street Psychiatry team, a model of mental health and addiction care delivery that takes physicians and other providers to the streets to provide care primarily to people who are experiencing unsheltered homelessness.

Dr. Arbelo Cruz graduated magna cum laude with a bachelors in science degree from the University of Puerto Rico and received her medical degree from the Ponce Health Sciences University School of Medicine. She completed general psychiatry residency at Boston Medical Center and was awarded the Chairman’s Award (the highest honor for a graduating resident in the BMC program) as she exceeded expectations in every domain-interpersonally, clinically, research, and humanism. Dr. Arbelo Cruz also completed an Addiction Psychiatry Fellowship at Yale.

Dr. Arbelo Cruz is the past recipient of the APA Travel Scholarship for Minority Medical Students and the Externship in Addiction Psychiatry Award, and AAAP John Renner award in 2021. She was accepted to the Yale REACH Scholar Program-a program aimed to adequately train physicians to work with minority patients with co-occurring mental health and substance use disorders.


At the conclusion of this activity, participants will have adequate knowledge to: 

1) Discuss the relationship between SUD and suicide risk

2) Apply strategies for assessment and intervention of suicidality in people with SUD

Sponsored by

Massachusetts Department of Public Health, Bureau of Substance Addiction Services (DPH/BSAS).

Funding for out of state attendees is provided by the Opioid Response Network (ORN).

Funding for this initiative was made possible (in part) by grant no. 1H79TI083343 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

Accreditation information

In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Boston University Chobanian & Avedisian School of Medicine designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Boston Medical Center grants 1.00 hours to all nurses who attend and complete the evaluation. Boston Medical Center is approved as a provider of nursing continuing professional development by American Nurses Association, Massachusetts, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation.

The lecture has been approved by The Network of Professional Education at Boston University School of Social Work,  accredited by the Commonwealth of Massachusetts Board of Social Work Registration, to provide 1.00 credit hours.

BMC Grayken Center of Addiction TTA has been approved by NBCC as an Approved Continuing Education Provider, ACEP No. 7188. Programs that do not qualify for NBCC credit are clearly identified. BMC Grayken Center of Addiction TTA is solely responsible for all aspects of the programs. For this program, 1.00 contact hours will be offered to participants who attend the training and complete the evaluation. 

Event sold-out

Join the waiting list

Grayken Center for Addiction TTA is a program of Boston Medical Center (BMC), a 514-bed academic medical center located in Boston's historic South End and the largest safety-net hospital in New England.

Funding for Grayken Center for Addiction TTA is provided by:

Massachusetts Department of Public Health Bureau of Substance Abuse Services (BSAS)
GE Foundation
Opioid Response Network

© 2023 Boston Medical Center. All rights reserved. Site by Root802.